Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,329 | -27,147 | -4,984 | -8,988 | -65,025 |
| Depreciation Amortization | 3 | 3 | 2 | 5 | 68 |
| Accounts receivable | -2,624 | 58 | -571 | -198 | 625 |
| Accounts payable and accrued liabilities | 1,063 | 547 | 386 | 944 | 250 |
| Other Working Capital | -2,216 | 603 | -1,750 | 264 | 8,377 |
| Other Operating Activity | -15,923 | 7,527 | -8,685 | 1,455 | 36,541 |
| Operating Cash Flow | $-25,026 | $-18,409 | $-15,602 | $-6,518 | $-19,164 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18,579 | 18,579 | 18,579 | 7,736 | -10,402 |
| Investing Cash Flow | $18,579 | $18,579 | $18,579 | $7,736 | $-10,402 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | -540 | N/A | 5,000 |
| Common Stock Issued | 16,465 | 5,829 | 703 | 533 | 24,519 |
| Other Financing Activity | -540 | -540 | 0 | -540 | -100 |
| Financing Cash Flow | $15,925 | $5,289 | $163 | $-7 | $29,419 |
| Beginning Cash Position | 14,949 | 14,949 | 14,949 | 14,949 | 15,096 |
| End Cash Position | 24,427 | 20,408 | 18,089 | 16,160 | 14,949 |
| Net Cash Flow | $9,478 | $5,459 | $3,140 | $1,211 | $-147 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,026 | -18,409 | -15,602 | -6,518 | -19,164 |
| Free Cash Flow | -25,026 | -18,409 | -15,602 | -6,518 | -19,164 |